Reduced expression of schwannomin/merlin in human sporadic meningiomas

Neurosurgery

Volumn 40, Issue 3, 1997, Pages 578-587

  Lee, Joung H ^a   Sundaram, Vidyodhaya ^a   James Stein, D ^a   Kinney, Sam E ^a   Stacey, Dennis W ^a   Golubic, Mladen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Meningioma; Merlin; Schwannomin; Tumor suppressor; Tumorigenesis

Indexed keywords

NERVE PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MENINGIOMA; NEUROFIBROMATOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ANIMALS; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEUROFIBROMATOSIS 2; HUMANS; MALE; MEMBRANE PROTEINS; MENINGEAL NEOPLASMS; MENINGES; MENINGIOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEUROFIBROMIN 2; RABBITS; RATS;

EID: 0031017806     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199703000-00031     Document Type: Article

References (42)

1. Akagi K, Kurahashi H, Arita N, Hayakawa T, Monden M, Mori T, Takai S, Nishisho I: Deletion mapping of the long arm of chromosome 22 in human meningiomas. Int J Cancer 60:178-182, 1995.
2. Algrain M, Turunen O, Vaheri A, Louvard D, Arpin M: Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol 120:129-139, 1993.
3. Arakawa H, Hayashi N, Nagase H, Ogawa M, Nakamura Y: Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers. Hum Mol Genet 3:565-568, 1994.
4. Bernai SD, Stahel RA: Cytoskeleton-associated proteins: Their role as cellular integrators in the neoplastic process. Crit Rev Oncol Hematol 3:191-204, 1985.
5. Bianchi AB, Hara T, Ramesh V, Gao J, Klein-Szanto AJP, Morin F, Menon AG, Trofatter JA, Gusella JF, Seizinger BR, Kley N: Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types. Nature Genet 6:185-192, 1994.
6. Bo L, Mork SJ, Nyland H: An immunohistochemical study of mononuclear cells in meningiomas. Neuropathol Appl Neurobiol 18:548-558, 1992.
7. Claudio JO, Marineau C, Rouleau GA: The mouse homologue of the neurofibromatosis type 2 gene is highly conserved. Hum Mol Genet 3:185-190, 1994.
8. Collins VP, Nordenskjold M, Dumanski JP: The molecular genetics of meningiomas. Brain Pathol 1:19-24, 1990.
9. den Bakker MA, Riegman PHJ, Hekman RAC, Boersma VV, Janssen PJA, van der Kwast TH, Zwarthoff EC: The product of the NF2 tumor suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells. Oncogene 10:757-763, 1995.
10. Doco-Fenzy M, Cornillet P, Scherpereel B, Depernet B, BisiauLeconte S, Ferre D, Pluot M, Graftiaux J-P, Teyssier J-R: Cytogenetic changes in 67 cranial and spinal meningiomas: Relation to histopathological and clinical pattern. Anticancer Res 13:845-850, 1993.
11. Gutmann DH, Wright DE, Geist RT, Snider VVD: Expression of the neurofibromatosis 2 (NF2) gene isoforms during rat embryonic development. Hum Mol Genet 4:47178, 1995.
12. Hara T, Bianchi AB, Seizinger BR, Kley N: Molecular cloning and characterization of alternatively spliced transcripts of the mouse neurofibromatosis 2 gene. Cancer Res 54:330-335, 1994.
13. Huynh DP, Nechiporuk T, Pulst S-M: Alternative transcripts in the mouse neurofibromatosis type 2 (NF2) gene are conserved and code for schwannomins with distinct C-terminal domains. Hum Mol Genet 3:1075-1079, 1994.
14. Kleihues P, Burger PC, Scheithauer BW: The new WHO classification of brain tumours. Brain Pathol 3:255-268, 1993.
15. Knudson AG: Mutation and cancer: Statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820-823, 1971.
16. Kujas M: Meningioma. Curr Opin Neurol Neurosurg 6:882-887, 1993.
17. Lekanne Deprez RH, Bianchi AB, Groen NA, Seizinger BR, Hagemeijer A, van Drunen E, Bootsma D, Köper JW, Avezaat CJJ, Kley N, Zwarthoff EC: Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas. Am J Hum Genet 54:1022-1029, 1994.
18. Lekanne Deprez RH, Riegman PHJ, Groen NA, Warringa UL, van Biezen NA, Molijn AC, Bootsma D, de Jong PJ, Menon AG, Kley NA, Seizinger BR, Zwarthoff EC: Cloning and characterization of MN1, a gene from chromosome 22qll, which is disrupted by a balanced translocation in a meningioma. Oncogene 10:1521-1528, 1995.
19. Luna EJ, Hitt AL: Cytoskeleton-plasma membrane interactions. Science 258:955-964, 1992.
20. Lutchman M, Rouleau AG: The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells. Cancer Res 55:2270-2274, 1995.
21. Martuza RL, Eldridge R: Medical progress: Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 318:684-688, 1988.
22. Murphy N, Chen J-N, George DL: Establishment and characterization of a human leptomeningeal cell line. J Neurosci Res 30:475-483, 1991.
23. Ng H-k, Lau K-m, Tse JYM, Lo K-w, Wong JHC, Poon W-s, Huang DP: Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors. Neurosurgery 37:764-773, 1995.
24. Peyrard M, Fransson I, Xie Y-G, Han F-Y, Ruttledge MH, Swahn S, Collins JE, Dunham I, Collins VP, Dumanski JP: Characterization of a new member of the human /3-adaptin gene family from chromosome 22q12, a candidate meningioma gene. Hum Mol Genet 3:1393-1399, 1994.
25. Pulst S-M, Rouleau GA, Marineau C, Fain P, Sieb JP: Familial meningioma is not allelic to neurofibromatosis 2. Neurology 43: 2096-2098, 1993.
26. Pykett MJ, Murphy M, Harnish PR, George DL: The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Hum Mol Genet 3:559-564, 1994.
27. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C, Hoang-Xuan K, Demczuk S, Desmaze C, Plougastel B, Pulst SM, Lenoir G, Bijlsma E, Fashold R, Dumanski J, de Jong P, Parry D, Eldridge R, Aurias A, Delattre O, Thomas G: Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature 363:515-520, 1993.
28. Rüssel DS, Rubinstein LJ: Tumours of the méninges and related tissues, in Rüssel DS, Rubinstein LJ (eds): Pathology of Tumours of the Nervous System. Baltimore, Williams & Wilkins, 1989, pp 449-532.
29. Ruttledge MH, Sarrazin J, Rangaratnam S, Phelan CM, Twist E, Merel P, Delattre O, Thomas G, Nordenskjold M, Collins VP, Dumanski JP, Rouleau GA: Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet 6:180-184, 1994.
30. Ruttledge MH, Xie YG, Han FY, Peyrard M, Collins VP, Nordenskjold M, Dumanski JP: Deletions on chromosome 22 in sporadic meningioma. Genes Chromosom Cancer 10:122-130, 1994.
31. Sachs AB: Messenger RNA degradation in eukaryotes. Cell 74: 413-421, 1993.
32. Sainz J, Huynh DP, Figueroa K, Ragge NK, Baser ME, Pulst S-M: Mutations of the neurofibromatosis type 2 gene and lack of the gene product in vestibular schwannomas. Hum Mol Genet 3:885-891, 1994.
33. Sato N, Funuyama N, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S: A gene family consisting of ezrin, radixin and moesin. J Cell Sci 103:131-143, 1992.
34. Scheithauer BVV: Tumors of the méninges: Proposed modifications of the World Health Organization classification. Acta Neuropathol (Berl) 80:343-354, 1990.
35. Seizinger BR, Do La Monte S, Atkins L, Gusella JF, Martuza RL: Molecular genetic approach to human meningioma: Loss of genes on chromosome 22. Proc Natl Acad Sci U S A 84:5419-5423, 1987.
36. Sekido Y, Pass H, Bader S, Mew DJY, Christman MF, Gazdar AF, Minna JD: Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227-1231, 1995.
37. Takeshima H, Izawa I, Lee PSY, Safdar N, Levin VA, Saya H: Detection of cellular proteins that interact with the NF2 tumor suppressor gene product. Oncogene 9:2135-2144, 1994.
38. Takeuchi K, Kawashima A, Nagafuchi A, Tsukita S: Structural diversity of band 4.1 superfamily members. J Cell Sci 107:1921-1928, 1994.
39. Tikoo A, Varga M, Ramesh V, Gusella J, Maruta H: An anti-Ras function of neurofibromatosis type 2 gene product (NF2/merlin). J Biol Chem 269:23387-23390, 1994.
40. Trofatter JA, MacCollin MM, Rutter JL, Murrell JR, Duyao MP, Parry DM, Eldridge R, Kley N, Menon AG, Pulaski K, Hasse VH, Ambrose CM, Munroe D, Bove C, Haines JL, Martuza RL, MacDonald ME, Seizinger BR, Short MP, Buckler AJ, Gusella JF: A novel meosin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72:791-800, 1993.
41. Twist EC, Ruttledge MH, Rousseau M, Sanson M, Papi L, Merel P, Delattre O, Thomas G, Rouleau GA: The neurofibromatosis type 2 gene is inactivated in schwannomas. Hum Mol Genet 3:147-151, 1994.
42. Wellenreuther R, Kraus JA, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, VViestler ÖD, von Deimling A: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 146:827-832, 1995.